Vimarsana
Biggest News Aggregation in the World

Page 4 - Population Based Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Population Based Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Population Based Study Today - Breaking & Trending Today

Frontiers | Cancer Screening Knowledge and Behavior in a Multi-Ethnic Asian Population: The Singapore Community Health Study - Vimarsana News

Frontiers | Cancer Screening Knowledge and Behavior in a Multi-Ethnic Asian Population: The Singapore Community Health Study

Background: Cancer has become the leading cause of mortality in Singapore and among other Asian populations worldwide. Despite the presence of National Cancer Screening programmes in Singapore, less than half of the population has had timely screening according to guidelines. The underlying factors of poor cancer screening rates and health outcomes among Asian ethnic groups remain poorly understood. We therefore examined cancer screening participation rates and screening behaviour in a multi-ethnic Singapore population. Methods: We collected data from 7,125 respondents of the 2015-2016 Singapo...

Janssen presentará pruebas sólidas de su cartera de tumores sólidos y su cartera de productos en ASCO GU 2021 - Iberonews - Vimarsana News

Janssen presentará pruebas sólidas de su cartera de tumores sólidos y su cartera de productos en ASCO GU 2021 - Iberonews

ó stata avanzado; presentaciones orales para destacar los resultados de los estudios de fase 3 ACIS, TITAN y SPARTAN SOLO PARA MEDIOS DE COMUNICACIÓN MÉDICOS Y COMERCIALES FARMACÉUTICOS DE LA REGIÓN DE EMEA NO SE PERMITE LA DISTRIBUCIÓN EN EL BENELUX NI EN EL REINO UNIDO Janssen Pharmaceutical Companies de Johnson & Johnson ha anunciado hoy que destacará la solidez de su cartera de tumores sólidos en el Simposio sobre Cánceres Genitourinarios de la Sociedad Americana de Oncología Clínica (American Society of Clinical Oncology Genitourinary, ASCO GU) con 12 presentaciones de datos,...

Janssen to Highlight Robust Solid Tumor Portfolio and Pipeline at 2021 ASCO GU - Vimarsana News

Janssen to Highlight Robust Solid Tumor Portfolio and Pipeline at 2021 ASCO GU

Janssen to Highlight Robust Solid Tumor Portfolio and Pipeline at 2021 ASCO GU Multiple data presentations to show long-term benefit and consistency of ERLEADA® (apalutamide) in advanced prostate cancer; oral presentations to highlight Phase 3 ACIS, TITAN and SPARTAN study results News provided by Share this article Share this article RARITAN, N.J., Feb. 2, 2021 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today it will highlight the depth of its solid tumor portfolio at the American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposiu...

10 Questions About Advanced Colon Cancer Treatment - Vimarsana News

10 Questions About Advanced Colon Cancer Treatment

10 Questions About Advanced Colon Cancer Treatment iStock You’ve gotten your initial diagnosis, which already was a shock. Now your doctor has more potentially bad news—your cancer has spread and you are among the 22% of patients who has stage 4, or advanced, colon cancer. Now what? You’ll probably have a lot of questions about your treatment plan and what you can expect. Here are some reassuring answers. iStock What does stage 4 cancer really mean? “The way that I approach thinking about staging is if you see cancer outside of the colon, that's metastatic disease, and that’s stage...